Cardiff Oncology Newsroom

Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $10

BenzingaDec 13 08:15 ET

Cardiff Oncology Analyst Ratings

BenzingaDec 13 08:14 ET

Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsDec 13 07:32 ET

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Moomoo NewsDec 13 07:31 ET

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Moomoo NewsDec 10 09:31 ET

Cardiff Oncology (CRDF) Gets a Buy From Craig-Hallum

TipRanksDec 10 08:59 ET

Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 8 14:40 ET

Cardiff Oncology Analyst Ratings

BenzingaNov 8 14:31 ET

H.C. Wainwright Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsNov 8 07:35 ET

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Moomoo NewsNov 7 23:31 ET

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsSep 11 09:31 ET

Cardiff Oncology Analyst Ratings

BenzingaSep 6 08:27 ET

Craig-Hallum Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $8

Moomoo NewsSep 6 07:33 ET

Cardiff Oncology Analyst Ratings

BenzingaMay 6 06:28 ET

HC Wainwright & Co. Reiterates Buy on Cardiff Oncology, Maintains $14 Price Target

BenzingaMay 6 06:28 ET

Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler

TipRanksMay 3 08:26 ET

Cardiff Oncology Analyst Ratings

BenzingaMar 6 06:50 ET

Cardiff Oncology Analyst Ratings

BenzingaMar 1 10:01 ET

Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler

TipRanksMar 1 07:48 ET

Positive Clinical Trials and Financial Stability Propel a Buy Rating for Cardiff Oncology: An Insight Into the Anticipated Success of CRDF-004 and CRDF-005 Trials

TipRanksNov 7, 2023 09:45 ET